Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice.

MLA

Martinez, David R., et al. “Prevention and Therapy of SARS-CoV-2 and the B.1.351 Variant in Mice.” Cell Reports, vol. 36, no. 4, July 2021, p. 109450. EBSCOhost, https://doi.org/10.1016/j.celrep.2021.109450.

APA

Martinez, D. R., Schäfer, A., Leist, S. R., Li, D., Gully, K., Yount, B., Feng, J. Y., Bunyan, E., Porter, D. P., Cihlar, T., Montgomery, S. A., Haynes, B. F., Baric, R. S., Nussenzweig, M. C., & Sheahan, T. P. (2021). Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Reports, 36(4), 109450. https://doi.org/10.1016/j.celrep.2021.109450

Chicago

Martinez, David R, Alexandra Schäfer, Sarah R Leist, Dapeng Li, Kendra Gully, Boyd Yount, Joy Y Feng, et al. 2021. “Prevention and Therapy of SARS-CoV-2 and the B.1.351 Variant in Mice.” Cell Reports 36 (4): 109450. doi:10.1016/j.celrep.2021.109450.